vs
Side-by-side financial comparison of Ameriprise Financial (AMP) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.
Ameriprise Financial is the larger business by last-quarter revenue ($4.9B vs $487.7M, roughly 10.0× CLOVER HEALTH INVESTMENTS, CORP.). Ameriprise Financial runs the higher net margin — 18.7% vs -10.1%, a 28.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 9.0%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 5.5%).
Ameriprise Financial, Inc., through its subsidiaries, provides various financial products and services to individual and institutional clients in the United States and internationally. It operates through four segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. The Advice & Wealth Management segment provides financial planning and advice; brokerage products and services for retail and institutional clients; discretionary and non-di...
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
AMP vs CLOV — Head-to-Head
Income Statement — Q1 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $4.9B | $487.7M |
| Net Profit | $915.0M | $-49.3M |
| Gross Margin | — | — |
| Operating Margin | — | -10.1% |
| Net Margin | 18.7% | -10.1% |
| Revenue YoY | 9.0% | 44.7% |
| Net Profit YoY | 57.0% | -123.2% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $4.9B | — | ||
| Q4 25 | $5.0B | $487.7M | ||
| Q3 25 | $4.9B | $496.6M | ||
| Q2 25 | $4.5B | $477.6M | ||
| Q1 25 | $4.5B | $462.3M | ||
| Q4 24 | $4.6B | $337.0M | ||
| Q3 24 | $4.6B | $331.0M | ||
| Q2 24 | $4.4B | $356.3M |
| Q1 26 | $915.0M | — | ||
| Q4 25 | $1.0B | $-49.3M | ||
| Q3 25 | $912.0M | $-24.4M | ||
| Q2 25 | $1.1B | $-10.6M | ||
| Q1 25 | $583.0M | $-1.3M | ||
| Q4 24 | $1.1B | $-22.1M | ||
| Q3 24 | $511.0M | $-9.2M | ||
| Q2 24 | $829.0M | $7.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 30.3% |
| Q1 26 | — | — | ||
| Q4 25 | 25.6% | -10.1% | ||
| Q3 25 | 24.0% | -4.9% | ||
| Q2 25 | 30.1% | -2.2% | ||
| Q1 25 | 15.3% | -0.3% | ||
| Q4 24 | 29.1% | -6.4% | ||
| Q3 24 | 14.1% | -2.7% | ||
| Q2 24 | 23.9% | 2.0% |
| Q1 26 | 18.7% | — | ||
| Q4 25 | 20.0% | -10.1% | ||
| Q3 25 | 18.6% | -4.9% | ||
| Q2 25 | 23.6% | -2.2% | ||
| Q1 25 | 13.0% | -0.3% | ||
| Q4 24 | 23.0% | -6.6% | ||
| Q3 24 | 11.2% | -2.8% | ||
| Q2 24 | 18.9% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | $10.39 | — | ||
| Q3 25 | $9.33 | — | ||
| Q2 25 | $10.73 | — | ||
| Q1 25 | $5.83 | — | ||
| Q4 24 | $10.57 | — | ||
| Q3 24 | $5.00 | — | ||
| Q2 24 | $8.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3B | $78.3M |
| Total DebtLower is stronger | $3.3B | — |
| Stockholders' EquityBook value | $355.9B | $308.7M |
| Total Assets | $184.4B | $541.0M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $8.3B | — | ||
| Q4 25 | — | $78.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $194.5M | ||
| Q3 24 | — | $288.0M | ||
| Q2 24 | — | $254.8M |
| Q1 26 | $3.3B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $355.9B | — | ||
| Q4 25 | $6.5B | $308.7M | ||
| Q3 25 | $6.5B | $340.9M | ||
| Q2 25 | $6.1B | $344.2M | ||
| Q1 25 | $5.4B | $336.1M | ||
| Q4 24 | $5.2B | $341.1M | ||
| Q3 24 | $5.7B | $342.2M | ||
| Q2 24 | $5.0B | $324.9M |
| Q1 26 | $184.4B | — | ||
| Q4 25 | $190.9B | $541.0M | ||
| Q3 25 | $190.1B | $559.7M | ||
| Q2 25 | $184.9B | $575.0M | ||
| Q1 25 | $179.1B | $583.7M | ||
| Q4 24 | $181.4B | $580.7M | ||
| Q3 24 | $186.0B | $653.0M | ||
| Q2 24 | $179.7B | $674.2M |
| Q1 26 | 0.01× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-68.2M |
| Free Cash FlowOCF − Capex | — | $-68.7M |
| FCF MarginFCF / Revenue | — | -14.1% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-69.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.7B | $-68.2M | ||
| Q3 25 | $2.2B | $12.1M | ||
| Q2 25 | $1.8B | $5.4M | ||
| Q1 25 | $1.7B | $-16.3M | ||
| Q4 24 | $383.0M | $-85.8M | ||
| Q3 24 | $3.0B | $50.0M | ||
| Q2 24 | $1.7B | $44.8M |
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $-68.7M | ||
| Q3 25 | $2.2B | $11.4M | ||
| Q2 25 | $1.7B | $4.8M | ||
| Q1 25 | $1.6B | $-16.5M | ||
| Q4 24 | $325.0M | $-86.1M | ||
| Q3 24 | $3.0B | $49.6M | ||
| Q2 24 | $1.7B | $44.4M |
| Q1 26 | — | — | ||
| Q4 25 | 52.0% | -14.1% | ||
| Q3 25 | 44.1% | 2.3% | ||
| Q2 25 | 38.4% | 1.0% | ||
| Q1 25 | 36.8% | -3.6% | ||
| Q4 24 | 7.0% | -25.6% | ||
| Q3 24 | 65.8% | 15.0% | ||
| Q2 24 | 38.8% | 12.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.9% | 0.1% | ||
| Q2 25 | 0.8% | 0.1% | ||
| Q1 25 | 0.8% | 0.0% | ||
| Q4 24 | 1.2% | 0.1% | ||
| Q3 24 | 1.1% | 0.1% | ||
| Q2 24 | 0.4% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 2.65× | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | 1.66× | — | ||
| Q1 25 | 2.89× | — | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | 5.96× | — | ||
| Q2 24 | 2.07× | 6.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMP
| Management and financial advice fees | $2.9B | 60% |
| Other | $872.0M | 18% |
| Distribution fees | $563.0M | 12% |
| Premiums, policy and contract charges | $341.0M | 7% |
| Other revenues | $166.0M | 3% |
CLOV
Segment breakdown not available.
